that a RIC’s income from investing in derivatives based on an index of physical commodities would not constitute RIC qualifying income, it did so prospectively, giving RICs that invested in such derivatives six months advance notice to change their
investments.(8) Given this historical, equitable approach, Registrant would expect a similar result here.
For these reasons, while the Registrant acknowledges that the
tax position of the Funds is not without any risk, Registrant believes that such risks are not unique to the Funds. Rather, Registrant respectfully submits that hundreds of
funds would be adversely affected by the Service taking a contrary view of the tax treatment of swaps for purposes of the diversification requirements of the Code.
(1) Internal Revenue Code section 851(b)(3).
(2) Other swaps may require initial premium (discount) payments as well as periodic payments (receipts) related to the interest leg of the swap or to the default of the reference entity.
(3)
See GCM 39316, (July 31, 1984); PLRs 8640059 (June 26, 1986) and 8549011, (August 30, 1985).
(4) See GCM
39316, (July 31, 1984); PLR 8823067, (March 11, 1988).
(5) See GCMs 39316, (July 31, 1984), and 39526 (July
21, 1986).
(6)
See GCMs 39316 (July 31, 1984) and 39526 (July 21, 1986).
(7) See, e.g., GCMs 39316 (July 31, 1984) and
39526 (July 21, 1986) and PLR 8640059, (June 26, 1986).
(8) See Revenue Ruling 2006-1, 2006-2 I.R.B.
261.
5) The Funds’ performance will be
driven by its exposure to a single underlying company. As a result, please include a footnote either in the Funds schedule of investments or financial
statements explaining where investors may view financial statements of the underlying company.
Registrant will include a footnote in either each Fund’s schedule of
investments or financial statements explaining where investors may view financial statements of the Company.
6) Please:
a. advise if the concentration of a particular counterparty
is likely to be material and if so please include disclosure about the counterparty. The type of information (e.g. whether financial statements of the
counterparty are required) will depend on the concentration level. At a minimum, a material counterparty should be identified in the prospectus. Other required disclosure relating to a material counterparty also would have to be provided in the prospectus unless it could be provided consistent with the Morgan Stanley No Action Letter dated July 8th, 2013. Please provide an analysis of these issues, as well as an analysis addressing general consistency of the fund and its swap investments with the Morgan Stanley No Action Letter;
Registrant respectfully submits that the Morgan Stanley Letter is inapposite to the Funds. With respect to each of its series, Registrant’s total exposure to any one counterparty individually, and all counterparties collectively, is at all times less than 25% of the assets of the Fund. Accordingly, Registrant does not believe that any Fund is concentrated with respect to a particular counterparty or counterparties, and no counterparty is identified in the
Prospectus.
b. ensure that all material features of the contemplated swap agreements have been disclosed. Please also provide an analysis as to whether the swap agreements are material contracts and are therefore required to be filed as exhibits;
The Funds confirm that the material features of the contemplated swap agreements have been disclosed. The Funds respectfully submit that the swap agreements do not constitute “material contracts not made in the ordinary course of business” that must be filed pursuant to Item 28(h) of Form N-1A. The Registrant has conducted a survey of various fund complexes’ filings and confirmed that, like Registrant, they do not file swap agreements as material contracts. The Registrant believes that this is appropriate because the swap agreements are made in the ordinary course of business as part of the
Funds’ investment strategies.
c. advise whether there is a limit on the extent to which
the Funds’ assets can be exposed to a single counterparty, and specify any relevant percentages; and,
While the Funds do not specifically limit their counterparty risk with
respect to any single counterparty, except to the extent required to qualify and maintain RIC status under Subchapter M of the Code, the Adviser regularly assesses and monitors the risks of, and exposure to, each counterparty. The Funds typically include provisions in their swap documentation that limit certain payments by one party to the other if the return is above or below a specified amount on any payment
date. In addition, the Funds generally include provisions in their swap agreements that provide that either party can terminate the contract without penalty prior to the termination date. The Adviser effects such terminations when needed to avoid
exposures that it deems to be inappropriate or excessive in the exercise of its fiduciary duties.
d. provide an analysis as to whether each underling issuer should be a co-registrant under Rule 140.
Section 2(a)(11) of the Securities Act of 1933, as amended (“Securities
Act”) defines an “underwriter” to mean, among other things, “any person who has purchased from an issuer with a view to, or offers or sells for an issuer
in connection with, the distribution of any security.” Rule 140 under the Securities Act, provides a definition of the term “distribution” in Section 2(a)(11) for certain transactions. In this respect, Rule 140 is important to determining whether a person is an underwriter of an issuer’s securities. Rule 140 provides in relevant part that “[a] person, the chief part of whose business consists of the purchase of the securities of one issuer…and the sale of its own securities… to furnish the proceeds with